CION Cancer Clinics
Primary sclerosing cholangitis: what it means for your cancer risk | CION Cancer Clinics
Primary sclerosing cholangitis (PSC) raises the risk of bile duct cancer, but most people with PSC never develop it. The risk is managed by regular scans, blood tests and, for many, colonoscopy. This page explains which cancers PSC makes more likely, how surveillance works, what the words on your report mean, and which symptoms need a hospital the same day. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
On this page
- Does primary sclerosing cholangitis lead to cancer?
- Which cancers does PSC make more likely?
- How is someone with PSC watched for cancer?
- What do the words on a PSC report mean?
- What families often believe about PSC, and what is true
- What this page cannot tell you
- Common questions about PSC and cancer risk
The short answer
Does primary sclerosing cholangitis lead to cancer?
Primary sclerosing cholangitis, usually shortened to PSC, raises the risk of bile duct cancer, but most people with PSC never develop it. The raised risk is the reason your doctors keep watching you with regular scans and blood tests, even when you feel well.
What PSC actually is
Bile is the digestive juice the liver makes. It drains out through a network of small tubes called bile ducts. In PSC, those ducts become inflamed and slowly scarred, so they narrow in some places and widen in others. Bile backs up, and over many years the liver itself can become scarred. Nobody yet knows exactly what starts it. It is not caused by alcohol, by diet or by anything the person did.
Why scarring raises cancer risk
Cells lining a duct that is inflamed for years keep repairing themselves. Each round of repair is another chance for a copying error, and occasionally one of those errors starts a cancer called cholangiocarcinoma. Our page on what cholangiocarcinoma is explains the cancer itself. This page is about the risk, and how it is watched.
PSC is a risk factor, not a diagnosis of cancer. Most people living with it are never told they have cancer.Where the risk sits
Which cancers does PSC make more likely?
PSC touches more than one organ, so the watch covers more than one place. These are the cancers your team has in mind.
Bile duct cancer
The main concern. It can start in ducts inside the liver or outside it, and is often hard to tell apart from the scarring PSC already causes. That is why a new narrowing on a scan gets careful attention.
Gallbladder cancer
People with PSC are more likely to have gallbladder polyps, and some polyps can turn cancerous. A polyp seen on ultrasound is usually reviewed by a surgeon. Gallbladder cancer is covered on our separate gallbladder cancer page.
Bowel cancer
Many people with PSC also have ulcerative colitis, an inflammation of the large bowel. Having both together raises bowel cancer risk more than colitis alone.
Usually means
- Regular colonoscopy, planned by a gastroenterologist
- Starting from the time PSC is found
- Continuing after a liver transplant
Liver cancer
Once PSC has caused cirrhosis, meaning heavy scarring of the whole liver, the risk of hepatocellular carcinoma (HCC), the commonest primary liver cancer, rises as it does in any cirrhosis.
Not sure whether this applies to you?
Ask an oncologistSurveillance
How is someone with PSC watched for cancer?
A regular scan of the ducts
Usually an MRI with a special sequence called MRCP, which draws a picture of the bile ducts without a needle or a tube. Many teams repeat it about once a year. CION arranges this scan through its diagnostic partners.
Blood tests
Liver tests and often a marker called CA 19-9. The marker can rise with plain infection or blockage, so one raised value is a reason to look closer, never a diagnosis on its own.
A closer look at anything new
A new tight narrowing, a growing lump or a fast-rising marker usually leads to an ERCP. A thin camera tube passes through the mouth to the ducts, and brushings or small samples are taken. Our page on MRCP, ERCP and cholangioscopy explains each test.
A review of the whole picture
Scan, samples and bloods are read together, ideally at a multidisciplinary tumour board. A narrowing caused by scar and one caused by cancer can look alike, so the decision rarely rests on one test.
Sudden yellowing of the eyes or skin together with fever, shivering or pain in the upper right side of the abdomen can mean an infected, blocked bile duct. Go to hospital today. Do not wait for your next planned scan, and do not treat it at home with herbal remedies first.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
What do the words on a PSC report mean?
- Stricture
- A narrowed section of bile duct. In PSC most strictures are scar. A dominant stricture is one tight enough to slow bile noticeably.
- Beading
- The typical PSC look on MRCP: ducts that narrow and widen in turn, like a string of beads.
- Cholangitis
- Inflammation of the bile ducts. When the word appears with fever, it usually means infection behind a blockage.
- CA 19-9
- A blood marker linked with bile duct and pancreas cancers. It also rises with infection and blockage, so it is read alongside the scan.
- Brush cytology
- Cells scraped from inside a duct during ERCP and checked under the microscope for cancer.
- Small-duct PSC
- A milder form affecting only the tiniest ducts. It carries a lower bile duct cancer risk than the usual type.
Commonly believed
What families often believe about PSC, and what is true
PSC has nothing to do with alcohol. It most often appears in young and middle-aged adults, many of whom have never drunk. Blame of this kind delays care and hurts the person carrying it.
Early bile duct cancer usually causes no symptoms at all. The point of the scan is to find a change while there is still time to act on it, which is exactly when the person feels well.
Most narrowings in PSC are scar. A new or changing one needs a closer look, and that look is what tells the two apart.
No tonic opens scarred ducts, and some herbal products injure an already damaged liver. If you take anything, tell your doctor exactly what it is. Nobody will judge you for it.
Being straight with you
What this page cannot tell you
It cannot tell you whether a narrowing on your own scan is scar or cancer. That needs the images, the blood results and often duct samples, read together by people who see PSC regularly. It also cannot set your surveillance plan. The right interval and tests depend on how long you have had PSC, whether you have colitis, and how scarred the liver is.
Who this page does not apply to
Primary biliary cholangitis sounds similar but is a different disease, mostly in women, affecting the smallest ducts. Its cancer picture is different, and it has its own page. Narrowed ducts caused by stones, surgery or old infection are also different, and are called secondary sclerosing cholangitis.
If cancer is found
A bile duct cancer found in someone with PSC should have its DNA tested, because some of these cancers carry changes that open targeted options. That does not promise one will be found. Our page on why molecular testing matters explains how this works.
If you have PSC and are unsure whether you are being watched properly, call the helpline. A CION oncologist can review your reports and tell you plainly.Questions we are asked
Common questions about PSC and cancer risk
Will I definitely get bile duct cancer if I have PSC?
No. PSC raises the risk, and most people with it never develop bile duct cancer. Surveillance exists so that, in the minority who do, any change is spotted as early as possible. Your oncologist or hepatologist can tell you how your own risk compares, based on your scans and history.
Is PSC itself a type of cancer?
No. PSC is a long-term inflammatory disease of the bile ducts. It is not cancer and does not spread like cancer. It is a condition in which cancer becomes more likely over time, which is why it is watched closely rather than simply treated and left.
How often should I have an MRCP scan?
Many specialists repeat it about once a year, alongside blood tests. The right interval for you depends on how long you have had PSC and what earlier scans showed. Your hepatologist sets it, and should tell you what change would bring the next scan forward.
Why do I need a colonoscopy for a liver disease?
Because PSC and ulcerative colitis so often occur together, and the combination raises bowel cancer risk. Colitis can be mild and go unnoticed. A colonoscopy checks for it and, if present, becomes part of regular surveillance planned by a gastroenterologist.
My CA 19-9 is high. Does that mean cancer?
Not by itself. CA 19-9 rises with infection and blockage in the ducts, both of which are common in PSC. A high value is a reason to repeat the test after any infection settles and to look again at the scan. A steadily rising value matters more than one reading.
Can medicines stop PSC turning into cancer?
No medicine has been shown to reliably prevent cancer in PSC. Some are used to ease symptoms or bile flow, and your hepatologist decides on those. The protection that exists comes from regular surveillance, prompt treatment of blockages and not ignoring new symptoms.
Does a liver transplant remove the cancer risk?
A transplant is sometimes needed when PSC causes liver failure, and it removes the diseased ducts. PSC can return in the new liver, and bowel surveillance continues if you have colitis. Transplant is arranged only at licensed transplant centres, and CION does not influence the waiting list.
Should my brother or children be tested for PSC?
PSC is slightly more common in close relatives, but there is no routine screening test for well family members. If a relative has long-standing bowel symptoms, itching or abnormal liver tests, they should mention your PSC to their doctor, who can decide whether to look further.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NIDDK — Primary Sclerosing Cholangitis - NIDDK
- American Cancer Society — Bile Duct Cancer Risk Factors
- National Cancer Institute — What Is Bile Duct Cancer (Cholangiocarcinoma)?
- Cancer Research UK — Bile duct cancer (Cholangiocarcinoma)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Not sure your PSC is being watched properly?
Send us your latest MRCP and blood reports and a CION oncologist will review them with you and explain what they show. One helpline serves every CION centre.